NCT06700538View on ClinicalTrials.gov

Study of ARO-INHBE in Adults With Obesity With and Without Diabetes Mellitus

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 4, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Obesity
Interventions
DRUG

ARO-INHBE

SC injection

DRUG

Placebo

calculated volume to match active treatment by SC injection

DRUG

Tirzepatide

SC injection

Trial Locations (3)

1010

RECRUITING

Research Site 1, Grafton

2025

RECRUITING

Research Site 3, Auckland

8011

RECRUITING

Research Site 2, Christchurch

Sponsors
All Listed Sponsors
lead

Arrowhead Pharmaceuticals

INDUSTRY